Rentschler Biopharma SE. (1/30/25). "Press Release: Rentschler Biopharma Announces Strategic Realignment of Its Global Business Operations". Laupheim. |
2025-01-30 |
Medix Biochemica Oy. (1/22/25). "Press Release: Medix Biochemica Expands Its Offering of Critical IVD Raw Materials to Premium Blockers and Stabilizers by Acquiring Candor Bioscience". Espoo. |
2025-01-22 |
Cormica Ltd.. (1/20/25). "Press Release: Cormica Expands European Operations with Acquisition of Zwisler Laboratorium GmbH". |
2025-01-20 |
Rentschler Biopharma SE. (1/16/25). "Press Release: Rentschler Biopharma Provides Update on Personnel Change in Company’s Extended Executive Team". |
2025-01-16 |
BioMed X GmbH. (1/14/25). "Press Release: BioMed X Institute Launches New Collaboration with Daiichi Sankyo in Cancer Therapy". Heidelberg. |
2025-01-14 |
CoreMedic GmbH. (1/10/25). "Press Release: CoreMedic Announces Partnership with InnoRa for Clinical Development of Transcatheter Mitral Valve Repair Device ChordArt". Basel & Philadelphia, PA. |
2025-01-10 |
Bruker Corporation. (12/20/24). "Press Release: Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility". Zürich. |
2024-12-20 |
Sanofi S.A.. (12/19/24). "Press Release: Jean-Paul Kress to Join Sanofi’s Board of Directors". Paris. |
2024-12-19 |
Max Planck Innovation GmbH. (12/17/24). "Press Release: Christoph Hüls Becomes Managing Director of Max Planck Innovation GmbH, Succeeding Jörn Erselius, Who Is Retiring after more than 30 Years of Service". |
2024-12-17 |
ITM Isotope Technologies Munich SE. (12/13/24). "Press Release: ITM to Present at the 43rd Annual J.P. Morgan Healthcare Conference". Garching / Munich. |
2024-12-13 |
Siemens Healthineers AG. (12/10/24). "Press Release: Siemens Healthineers Acquires Advanced Accelerator Applications Molecular Imaging". |
2024-12-10 |
Formycon AG. (12/9/24). "Press Release: MS Pharma Becomes Partner for the Commercialization of FYB202 / Ustekinumab in the MENA Region". Planegg-Martinsried. |
2024-12-09 |
Leon-Nanodrugs GmbH. (12/5/24). "Press Release: Feasibility Study with Evonik Confirms Leon’s FR-JET Technology’s Performance in Advanced Nanoparticle Manufacturing for Drug Delivery". Munich, Planegg. |
2024-12-05 |
Tubulis GmbH. (12/3/24). "Press Release: Gilead and Tubulis Enter into Exclusive Option and Licence Agreement to Develop ADC Candidate for Select Solid Tumor Target". Foster City, CA & Munich. |
2024-12-03 |
Bio Inx B.V.. (11/27/24). "Press Release: Bio Inx and Carl Roth Partner to Expand Access to 3D Bioprinting Solutions". Ghent. |
2024-11-27 |
Medigene AG. (11/26/24). "Press Release: Medigene AG Announces Refocus of Corporate Strategy and Organizational Realignment". Basel. |
2024-11-26 |
Adragos Pharma GmbH. (11/25/24). "Press Release: Adragos Pharma Acquires Baccinex – a Leading Swiss Sterile Fill-Finish Expert". Munich & Courroux. |
2024-11-25 |
Bico Group AB. (11/21/24). "Press Release: Bico Has Entered into an Agreement to Divest Nanoscribe". |
2024-11-21 |
Mainz Biomed N.V.. (11/12/24). "Press Release: Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets". Berkeley, CA & Mainz. |
2024-11-12 |
Bertelsmann Investments. (11/7/24). "Press Release: Bertelsmann Investments Makes Further Investments in Fast-growing Digital Health Market". Gütersloh. |
2024-11-07 |
Rock Capital Group. (11/5/24). "Press Release: Praimera Biotech AG Rents 600 m² of Lab Office Space at Skygate in Hallbergmoos near Munich". Munich-Hallbergmoos. |
2024-11-05 |
Kynos Therapeutics Ltd.. (10/29/24). "Press Release: Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio". Freiburg. |
2024-10-29 |
Aignostics GmbH. (10/29/24). "Press Release: Aignostics Secures $34M Series B to Enhance Precision Medicine with AI". Berlin & New York, NY. |
2024-10-29 |
Rentschler Biopharma SE. (10/24/24). "Press Release: Rentschler Biopharma Announces Largest Single Investment at Its Headquarters in Germany". Laupheim. |
2024-10-24 |
Bruker Corporation. (10/2/24). "Press Release: Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery". Munich. |
2024-10-02 |
Aitiologic GmbH. (10/1/24). "Press Release: Aitiologic Emerges from Stealth Mode with over €2.5M in Funding to Advance AI-powered Liquid Biopsy Platform for Early Disease Detection". Vienna. |
2024-10-01 |
Eleva GmbH. (9/19/24). "Press Release: Eleva Appoints Dr. Elisabeth Lackner to Its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization". Freiburg im Breisgau. |
2024-09-19 |
Messe München GmbH. (9/19/24). "Press Release: Analytica Expands Its International Network to the USA. Analytica USA Celebrates Its Premiere in Columbus, Ohio in September 2025". Munich. |
2024-09-19 |
Subject Well, Inc. (SubjectWell). (9/17/24). "Press Release: SubjectWell Announces Strategic Acquisition of Trials24 to Expand Global Patient Recruitment Capabilities". |
2024-09-17 |
High-Tech Gründerfonds Management GmbH. (9/16/24). "Press Release: Symphera Secures €2.4 Million in Seed Financing to Revolutionize Laparoscopic Surgery". Munich. |
2024-09-16 |
ions.bio GmbH. (9/13/24). "Press Release: ions.bio Announces Development of Revolutionary All-in-One Biomarker Discovery Platform". Munich. |
2024-09-13 |
Inflammatix, Inc.. (9/12/24). "Press Release: Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis". Sunnyvale, CA. |
2024-09-12 |
CPTx GmbH. (9/12/24). "Press Release: CPTx Secures $29 Million to Advance Breakthrough Antiviral Platform". Planegg. |
2024-09-12 |
MC Services AG. (9/11/24). "Press Release: MC Services Appoints Katja Arnold to Management Board". Munich & Düsseldorf. |
2024-09-11 |
Sofinnova Partners. (9/10/24). "Press Release: Sofinnova Partners Appoints Karl Naegler as Partner". Paris. |
2024-09-10 |
Medigene AG. (9/5/24). "Press Release: Medigene Announces U.S. FDA Clearance of IND Application for MDG1015 for Multiple Solid Tumor Indications". Planegg. |
2024-09-05 |
Certania Holding GmbH. (9/4/24). "Press Release: Alphalytik Joins Certania Group. The Specialist in Pharmaceutical Analytical Testing Becomes Part of the Certania Family". Berlin & Munich. |
2024-09-04 |
Irubis GmbH. (8/29/24). "Press Release: Acceleration of Bioprocess Development. Irubis Secures Pre-Series A Funding Led by BioProcess360 Partners". Munich. |
2024-08-29 |
InflaRx N.V.. (8/27/24). "Press Release: InflaRx Announces Participation in September Investor Events". Jena. |
2024-08-27 |
Medigene AG. (8/8/24). "Press Release: Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers". Planegg-Martinsried. |
2024-08-08 |
PolyPeptide Group AG. (8/8/24). "Press Release: PolyPeptide Appoints Chief Commercial Officer". Baar. |
2024-08-08 |
AGC Biologics. (8/7/24). "Press Release: NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines". |
2024-08-07 |
Bruker Corporation. (8/7/24). "Press Release: Bruker Announces Strategic Minority Investment in Novalix". |
2024-08-07 |
Leon-Nanodrugs GmbH. (8/6/24). "Press Release: Leon-Nanodrugs Secures Funds in a Series D Financing to Broaden Portfolio in First Single-use High Throughput Production Systems for Nanoencapsulation". Munich. |
2024-08-06 |
SphingoTec GmbH. (8/6/24). "Press Release: SphingoTec Closes €5M Series C to Accelerate Market Development and Financial Growth with Innovative Biomarkers". Richmond, CA. |
2024-08-06 |
Systasy Bioscience GmbH. (7/31/24). "Press Release: Systasy Bioscience Announces Collaboration Agreement with Ono Pharmaceutical". Munich. |
2024-07-31 |
Deepc GmbH. (7/24/24). "Press Release: Deepc Closes Series A Extension to Accelerate Global Deployment of Healthcare AI, Bringing Total Funding to $30m". Munich. |
2024-07-25 |
Oxford Biomedica plc. (7/17/24). "Press Release: Oxford Biomedica Announces Chief Financial Officer Transition. Lucinda Crabtree to Join as Chief Financial Officer". Basel. |
2024-07-17 |
IZB Martinsried. (7/17/24). "Press Release: Life Science Pitch Day at the IZB. Innovations Meet Investors". Martinsried. |
2024-07-17 |
Full-Life Technologies. (7/17/24). "Press Release: Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Therapeutic Targeting Multiple Solid Tumors". Heidelberg & Seoul. |
2024-07-17 |
Corden Pharma International GmbH. (7/16/24). "Press Release: CordenPharma Invests €900m in Transformational Peptide Platform Expansion in the USA & Europe". Basel. |
2024-07-16 |
Catalym GmbH. (7/16/24). "Press Release: Catalym Announces New Financing of $150M to Support Broad Phase 2b Development Program for Visugromab". Munich. |
2024-07-16 |
NanoTemper Technologies GmbH. (7/12/24). "Press Release: NanoTemper Technologies Establishes Advisory Board to Propel Innovation and Growth". Munich. |
2024-07-12 |
Rentschler Biopharma SE. (7/11/24). "Press Release: Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts Is Fully Operational". Laupheim & Milford, MA. |
2024-07-11 |
HepaRegenix GmbH. (7/10/24). "Press Release: HepaRegeniX Raises €15 Million Series C Round to Advance Clinical Development of HRX-215 for Liver Regeneration". Tübingen. |
2024-07-10 |
SciRhom GmbH. (7/9/24). "Press Release: SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases". Munich. |
2024-07-09 |
BioRN Cluster Management GmbH. (7/8/24). "Press Release: Advancing Personalised Medicine in Europe. BioRN Is Part of the Renowned EU Research Project PRECISEU". Heidelberg. |
2024-07-08 |
CureVac N.V.. (7/3/24). "Press Release: CureVac Initiates Strategic Restructuring to Align Resources with Focus on High-Value mRNA Pipeline Opportunities". Tübingen & Boston, MA. |
2024-07-03 |
CureVac N.V.. (7/3/24). "Press Release: GSK and CureVac to Restructure Collaboration into New Licensing Agreement". London, Tübingen & Boston, MA. |
2024-07-03 |
Full-Life Technologies. (7/3/24). "Press Release: Full-Life Technologies Granted FDA Fast Track Designation for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer". Heidelberg. |
2024-07-03 |
Heidelberg Epignostix GmbH. (7/2/24). "Press Release: DKFZ Spin-off Epignostix Raises €4.3m Seed Round to Commercialize Diagnostic Tumor Classifier". Heidelberg. |
2024-07-02 |
Bruker Corporation. (7/2/24). "Press Release: Bruker Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin". Berlin. |
2024-07-02 |
BioM Biotech Cluster Development GmbH. (6/26/24). "Press Release: MAxL in Martinsried. Bio M Opens New Start-up Incubator – 8.5 Million Euros for Innovative Start-up Teams to Strengthen Biotechnology in Bavaria". |
2024-06-26 |
Rock Capital Group. (6/25/24). "Press Release: Plectonic Logibody Moves into approx. 1,350 m² of Lab Offices at SKYGATE in Hallbergmoos near Munich". Munich-Hallbergmoos. |
2024-06-25 |
Allecra Therapeutics GmbH. (6/24/24). "Press Release: Allecra Therapeutics and Acino Sign Exclusive Licensing and Supply Agreement for Allecra’s Novel Antibiotic Exblifeb in Gulf Cooperation Council countries and South Africa". Saint-Louis, Weil am Rhein |
2024-06-24 |
ITM Isotope Technologies Munich SE. (6/20/24). "Press Release: ITM Appoints Dr. Andrew Cavey as CEO to Lead Organization in its Next Stage of Growth". Garching. |
2024-06-20 |
Wacker Chemie AG. (6/19/24). "Press Release: Wacker & CordenPharma Enter Pandemic Readiness on 1 June 2024 After Successful Expansion & Qualification". Munich, Halle (Saale) & Basel. |
2024-06-19 |
Ethris GmbH. (6/18/24). "Press Release: Ethris Announces $5 Million in Funding to Prepare Lead Candidate ETH47 for Phase 2 Stud". Munich. |
2024-06-18 |
Ethris GmbH. (6/18/24). "Press Release: Cipla EU to Invest an Additional EUR 3 Million in Ethris". Mumbai & Munich. |
2024-06-18 |
SciRhom GmbH. (6/12/24). "Press Release: SciRhom Announces Approval of First Clinical Trial Application for a Novel iRhom2-targeting Antibody Against Autoimmune Diseases". Munich. |
2024-06-12 |
Thermosome GmbH. (6/11/24). "Press Release: Thermosome Appoints Dr. Sabine Hauck as Chief Technical Officer". Munich. |
2024-06-11 |
ITM Isotope Technologies Munich SE. (6/6/24). "Press Release: ITM Raises €188m to Enhance Radiopharmaceutical Pipeline and to Strengthen Leading Position in Medical Radioisotope Manufacturing". Garching. |
2024-06-06 |
MorphoSys AG. (6/6/24). "Press Release: Arkadius Pichota and Lukas Gilgen Appointed to Management Board of MorphoSys AG Replacing the Current CEO and CFO (Ad hoc)". Planegg. |
2024-06-06 |
Wacker Chemie AG. (6/3/24). "Press Release: Wacker Opens mRNA Competence Center in Halle an der Saale, Germany". Munich & Halle (Saale). |
2024-06-03 |
Lumicks Technologies B.V.. (5/29/24). "Press Release: Lumicks Appoints Hugo de Wit as CEO and Executive Board Director". Amsterdam. |
2024-05-29 |
Rentschler Biopharma SE. (5/28/24). "Press Release: Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management". Laupheim, Milford, MA & Stevenage. |
2024-05-28 |
Origenis GmbH. (5/28/24). "Press Release: OncoBone Ventures and Origenis Announce Partnership to Develop Novel Therapies for Cancer Bone Metastasis". Tübingen & Boston, MA. |
2024-05-28 |
CureVac N.V.. (5/28/24). "Press Release: CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK". Tübingen & Boston, MA. |
2024-05-28 |
TVM Capital Healthcare. (5/28/24). "Press Release: TVM Capital Healthcare Announces the Closing of Its Saudi Arabia-Focused TVM Healthcare Afiyah Fund
". Riyadh. |
2024-05-28 |
Eisbach Bio GmbH. (5/24/24). "Press Release: Eisbach Bio Announces Successful Completion of Phase I Clinical Trial of Nucleic Acid Helicase Inhibitor EIS-10700 with Excellent Safety Properties". Martinsried. |
2024-05-24 |
Daiichi Sankyo Co., Ltd.. (5/22/24). "Press Release: Daiichi Sankyo Establishes Two Research Institutes in the U.S. and EU". |
2024-05-22 |
Molecular Health GmbH. (5/15/24). "Press Release: Integrated DNA Technologies and Molecular Health Ink Commercial Partnership". Coralville, IA & Heidelberg. |
2024-05-15 |
NeoSphere Biotechnologies GmbH. (5/14/24). "Press Release: NeoSphere Biotechnologies Partners with Kymera Therapeutics for Novel Molecular Glue Target Discovery". Martinsried. |
2024-05-14 |
Insempra GmbH. (5/7/24). "Press Release: Insempra Completes $20 Million Financing to Advance the Development of Next-generation Bio-based Ingredients". Munich. |
2024-05-07 |
Eisbach Bio GmbH. (5/6/24). "Press Release: Eisbach Bio Announces FDA Clearance of IND Application for EIS-12656, a First-in-Class Allosteric Inhibitor of ALC1". Martinsried. |
2024-05-06 |
Wacker Chemie AG. (5/6/24). "Press Release: Wacker Expands Production Capacity for Biopharmaceuticals in San Diego". Munich & San Diego, CA. |
2024-05-06 |
Rentschler Biopharma SE. (5/2/24). "Press Release: Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary". Laupheim, Milford, MA & Stevenage. |
2024-05-02 |
Variantyx, Inc.. (4/26/24). "Press Release: Variantyx Secures $36M Investment as Testing Demand and Market Share Continues to Increase". Framingham, MA. |
2024-04-26 |
CureVac N.V.. (4/24/24). "Press Release: CureVac Appoints Thaminda Ramanayake as New Chief Business Officer". Tübingen & Boston, MA. |
2024-04-24 |
Smart Reporting GmbH. (4/22/24). "Press Release: Smart Reporting Successfully Closes Financing Round for 23 Million Euros". Munich. |
2024-04-22 |
Robert Bosch GmbH. (4/18/24). "Press Release: Additional Partnership in Medical Technology –
Bosch and R-Biopharm to Strengthen Vivalytic Analysis platform". Darmstadt, Gerlingen & Waiblingen. |
2024-04-18 |
CureVac N.V.. (4/16/24). "Press Release: CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines". Tübingen & Houston, TX. |
2024-04-16 |
FundaMental Pharma GmbH. (4/11/24). "Press Release: FundaMental Pharma Appoints Dr. Dirk Beher as Chief Executive Officer". Heidelberg. |
2024-04-11 |
Robert Bosch GmbH. (4/10/24). "Press Release: Growth through Medical Technology – Bosch and Randox Invest Heavily in the Vivalytic Analysis Platform". Crumlin, Gerlingen & Waiblingen. |
2024-04-10 |
ProBioGen AG. (3/27/24). "Press Release: ProBioGen and DioSynVax Partner to Manufacture Groundbreaking Multivalent Vaccine for Hemorrhagic Fever". Berlin. |
2024-03-27 |
CMS Hasche Sigle. (3/26/24). "Press Release: CMS Advises Sellers of Cardior Pharmaceuticals on Potential Acquisition by Novo Nordisk". Munich. |
2024-03-26 |
OpGen, Inc.. (3/25/24). "Press Release: OpGen Announces Acquisition of Preferred Stock by David Lazar". Rockville, MD. |
2024-03-25 |
Kranus Health GmbH. (3/25/24). "Press Release: Kranus Health Increases Funding to USD 20 Million Total, Cementing Its Position as a Leader in Virtual Care in Urology". Berlin, Munich & Paris. |
2024-03-25 |
Eisbach Bio GmbH. (3/21/24). "Press Release: Eisbach and Cancer Focus Fund Announce $4.5 Million Investment to Support First-in-Human Phase 1/2 Trial of EIS-12656 for Refractory Advanced Solid Tumors". Martinsried & Houston, TX. |
2024-03-21 |
Climedo Health GmbH. (3/20/24). "Press Release: Climedo Establishes Advisory Board to Enter its Next Growth Chapter". Munich. |
2024-03-20 |